A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2 hour monitoring of neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction

✍ Scribed by M Cantarovich; H Ross; J Arizon; J Orus; L Straatman; J Howlett; E Lage; M Crespo; S Wang; H Haddad; L Pulpon; I Andres; W Hauck

• Book ID: 116517832
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 75 KB
• Volume: 23
• Category: Article
• ISSN: 1557-3117
• DOI: 10.1016/j.healun.2003.11.196